- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/49 - Platelet-derived growth factor [PDGF]
Patent holdings for IPC class C07K 14/49
Total number of patents in this class: 125
10-year publication summary
|
10
|
9
|
8
|
15
|
12
|
10
|
8
|
18
|
5
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ubiprotein, Corp. | 12 |
7 |
| X-body, Inc. | 45 |
5 |
| LG Household & Health Care Ltd. | 1206 |
3 |
| University of Mississippi Medical Center | 69 |
3 |
| Novartis AG | 10829 |
2 |
| American Gene Technologies International Inc. | 93 |
2 |
| Board of Trustees of the University of Arkansas | 812 |
2 |
| BrainStorm Cell Therapeutics Ltd. | 20 |
2 |
| The Brigham and Women's Hospital, Inc. | 2186 |
2 |
| Cornell University | 3307 |
2 |
| IL Dong Pharmaceutical Co., Ltd. | 30 |
2 |
| JCR Pharmaceuticals Co., Ltd. | 224 |
2 |
| The Kitasato Institute | 151 |
2 |
| Loma Linda University Medical Center | 105 |
2 |
| Molecular Partners AG | 110 |
2 |
| Montefiore Medical Center | 82 |
2 |
| National University Corporation Kagawa University | 211 |
2 |
| The Research Foundation for The State University of New York | 1622 |
2 |
| Trustees of Tufts College | 880 |
2 |
| The University of Chicago | 1412 |
2 |
| Other owners | 75 |